No. |
Variant name |
Chromosome position |
Chromatin state |
Related regulatory elements |
Target genes |
Extended variants |
Associated traits |
1 |
rs9848466 |
chr3:155755327-155755328 |
Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
LD-proxies of rSNPOverlapped rCNV
|
mRNA abundance
|
2 |
rs544323724 |
chr3:155755328-155755329 |
Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
3 |
rs113841314 |
chr3:155755354-155755355 |
Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
4 |
rs189928383 |
chr3:155755358-155755359 |
Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
5 |
rs73161007 |
chr3:155755360-155755361 |
Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
6 |
rs537330937 |
chr3:155755365-155755366 |
Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
7 |
rs140184395 |
chr3:155755396-155755397 |
Enhancers Weak transcription Active TSS
|
TF binding region
|
1 gene(s)
|
Overlapped CNVs
|
n/a
|
8 |
rs13061305 |
chr3:155755501-155755502 |
Enhancers Weak transcription Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
9 |
rs576930607 |
chr3:155755504-155755505 |
Enhancers Weak transcription Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
10 |
rs143875340 |
chr3:155755515-155755516 |
Enhancers Weak transcription Active TSS
|
lncRNA
|
n/a
|
Overlapped CNVs
|
n/a
|
11 |
rs567098240 |
chr3:155755564-155755565 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
12 |
rs553109911 |
chr3:155755574-155755575 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
13 |
rs181367912 |
chr3:155755582-155755583 |
Enhancers Weak transcription Active TSS
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
14 |
rs66771135 |
chr3:155755627-155755628 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
15 |
rs563906089 |
chr3:155755663-155755664 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
16 |
rs531135580 |
chr3:155755670-155755671 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
17 |
rs116970352 |
chr3:155755699-155755700 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
18 |
rs564402515 |
chr3:155755705-155755706 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
19 |
rs186020379 |
chr3:155755718-155755719 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
20 |
rs189873965 |
chr3:155755740-155755741 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
21 |
rs146792601 |
chr3:155755823-155755824 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
22 |
rs71310459 |
chr3:155755827-155755828 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
23 |
rs537910796 |
chr3:155755847-155755848 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
24 |
rs375691982 |
chr3:155755874-155755875 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
25 |
rs548130662 |
chr3:155755900-155755901 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
26 |
rs569818668 |
chr3:155755920-155755921 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
27 |
rs199876539 |
chr3:155755938-155755939 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
28 |
rs548576483 |
chr3:155755946-155755947 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
29 |
rs558914282 |
chr3:155755952-155755953 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
30 |
rs570712487 |
chr3:155755957-155755958 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
31 |
rs181864920 |
chr3:155755958-155755959 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
32 |
rs186270411 |
chr3:155755970-155755971 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
33 |
rs190344015 |
chr3:155755986-155755987 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
34 |
rs541888583 |
chr3:155755993-155755994 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
35 |
rs57402667 |
chr3:155756012-155756013 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
36 |
rs397953240 |
chr3:155756013-155756014 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
37 |
rs200245688 |
chr3:155756015-155756016 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
38 |
rs557304514 |
chr3:155756031-155756032 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
39 |
rs535672132 |
chr3:155756100-155756101 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
40 |
rs183740404 |
chr3:155756102-155756103 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
41 |
rs545957311 |
chr3:155756138-155756139 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
42 |
rs564442095 |
chr3:155756207-155756208 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
43 |
rs367853231 |
chr3:155756224-155756225 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
44 |
rs554029161 |
chr3:155756260-155756261 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
45 |
rs60683789 |
chr3:155756334-155756335 |
Weak transcription Enhancers
|
n/a
|
n/a
|
LD-proxies of rSNPOverlapped rCNV
|
n/a
|
46 |
rs75209292 |
chr3:155756352-155756353 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
47 |
rs562109346 |
chr3:155756389-155756390 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
48 |
rs114724842 |
chr3:155756398-155756399 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
49 |
rs572289165 |
chr3:155756491-155756492 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|
50 |
rs113973639 |
chr3:155756498-155756499 |
Weak transcription Enhancers
|
n/a
|
n/a
|
Overlapped CNVs
|
n/a
|